Welwyn Garden City, United Kingdom

Ruchi Upmanyu

USPTO Granted Patents = 3 


 

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 8(Granted Patents)


Location History:

  • Welwyn Garden City, GB (2018 - 2020)
  • Welwyn Garden, GB (2023)

Company Filing History:


Years Active: 2018-2023

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Ruchi Upmanyu: Innovator in Cardiovascular Therapeutics

Introduction

Ruchi Upmanyu is a notable inventor based in Welwyn Garden City, GB. She has made significant contributions to the field of cardiovascular therapeutics, holding a total of 3 patents. Her work focuses on innovative methods and compositions that aim to improve patient outcomes in cardiovascular disease.

Latest Patents

Among her latest patents, Ruchi has developed genotyping methods and compositions for selecting patients with cardiovascular disease who will benefit from treatment with HDL-raising or HDL mimicking agents, particularly with CETP inhibitors/modulators. This invention is crucial for identifying the right patients for effective treatment, thereby enhancing therapeutic efficacy.

Career Highlights

Ruchi has worked with prominent companies in the pharmaceutical industry, including Hoffmann-La Roche Inc. and F. Hoffmann-La Roche AG. Her experience in these organizations has allowed her to contribute to groundbreaking research and development in the field of cardiovascular health.

Collaborations

Ruchi has collaborated with esteemed colleagues such as Marie-Pierre Dube and Eric Joseph Niesor. These partnerships have further enriched her research and innovation efforts.

Conclusion

Ruchi Upmanyu's work in developing CETP inhibitors and her dedication to improving cardiovascular treatment options highlight her as a significant figure in medical innovation. Her contributions continue to pave the way for advancements in patient care and therapeutic strategies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…